Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety Study to Evaluate the Use of Nebulized Heparin in Patients With Severe Acute Respiratory Syndrome Covid-19 (SARS-CoV-2)

NCT04530578 is registered in ClinicalTrials.gov with Clinica San Camilo, Argentina as lead sponsor.

NCT NCT04530578
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04530578 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety Study to Evaluate the Use of Nebulized Heparin in Patients With Severe Acute Respiratory Syndrome Covid-19 (SARS-CoV-2)
Lead sponsor
Clinica San Camilo, Argentina
Phase
Phase 4
Overall status
Unknown status
Start date
June 1, 2020
Completion date
June 1, 2021
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19, pneumonia